Significant progress has been made in recent years regarding the subclassification of PCa based on the genetic alterations in the tumor cells, including chromosomal rearrangements involving ETS family transcription factors or overexpression of SPINK1, a gene encoding a secreted serine protease inhibitor. Here, SPINK1 is linked to neoplasm.